Macular Degeneration Research Update

July 01, 2020

Macular Degeneration Research Update

This month, the July issue of our monthly newsletter summarises some of the current research being conducted on treatments for Age-related Macular Degeneration.


Macular degeneration is the leading cause of blindness in Australia, with its prevalence predicted to increase as the average age of Australians increases. Currently, 1 in 7 elderly Australians over the age of 50 are affected by age-related macular degeneration.


Researchers are looking at more effective drugs and stem-cell therapy in order to provide alternatives to the currently used monthly eye injections. Hopefully these new treatment options will prove cheaper, more convenient, and more accessible to the many people suffering from macular degeneration.


Symptoms of macular degeneration include a loss of central vision, but preservation of peripheral, or side, vision. It is critical for health providers to diagnose it early in order to prevent significant vision loss, especially as macular degeneration is not an inevitable consequence of aging. 


Mobile Eye Clinic's optometrists are experienced in identifying aged-related macular degeneration.




Read the full newsletter here: